Catalent Inc
CTLT
Common Stock
$49.42
Sector: Health Care
Industry: Pharmaceuticals
Sub-Industry: Pharmaceuticals
|
|
|
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | $2.83 | $3.11 | $1.14 | $0.90 | $0.63 |
Sales/Revenue | $4.83 B | $4.00 B | $3.09 B | $2.52 B | $2.46 B |
Sales Growth | 20.76% | 29.21% | 22.89% | 2.22% | 0.00% |
Gross Margin | +33.97 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | $503.00 M | $529.00 M | $173.00 M | $132.00 M | $84.00 M |
Net Income Growth | -4.91% | 205.78% | 31.06% | 57.89% | 0.00% |
Net Margin | +10.42 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | $1.17 B | $962.00 M | $662.00 M | $541.00 M | $478.00 M |
Cost of Goods Sold (incl D&A) | $3.19 B | $2.65 B | $2.05 B | $1.66 B | $1.67 B |
Cost of Goods Sold (excl D&A) | $2.81 B | $2.36 B | $1.80 B | $1.43 B | $1.48 B |
Cost of Goods Growth | 20.48% | 29.09% | 23.36% | -0.17% | 0.00% |
Research & Development | $23.00 M | $21.00 M | $64.00 M | $55.00 M | $53.00 M |
Other SG&A Expenses | $0.00 M | $658.00 M | $572.00 M | $489.00 M | $459.00 M |
Interest Expense | $123.00 M | $110.00 M | $126.00 M | $111.00 M | $111.00 M |
Income Tax | $86.00 M | $130.00 M | $40.00 M | $23.00 M | $68.00 M |
2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | $1.03 | $0.78 | $0.53 | $0.49 |
Sales/Revenue | $1.31 B | $1.27 B | $1.22 B | $1.03 B |
Sales Growth | 3.14% | 4.60% | 18.73% | -13.72% |
Gross Margin | +33.97 | 0.00 | 0.00 | 0.00 |
Net Income | $187.00 M | $141.00 M | $93.00 M | $84.00 M |
Net Income Growth | 32.62% | 51.61% | 10.71% | -49.70% |
Net Margin | +10.42 | 0.00 | 0.00 | 0.00 |
EBITDA | $361.00 M | $321.00 M | $283.00 M | $229.00 M |
Cost of Goods Sold (incl D&A) | $825.00 M | $850.00 M | $812.00 M | $701.00 M |
Cost of Goods Sold (excl D&A) | $725.00 M | $751.00 M | $714.00 M | $620.00 M |
Cost of Goods Growth | -2.94% | 4.68% | 15.83% | -6.41% |
Research & Development | $5.00 M | $6.00 M | $6.00 M | $6.00 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $169.00 M |
Interest Expense | $32.00 M | $33.00 M | $32.00 M | $30.00 M |
Income Tax | $23.00 M | $35.00 M | $18.00 M | $10.00 M |
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $3.22 B | $2.61 B | $2.00 B | $1.54 B | $1.27 B |
Cash and Short-Term Investment | $538.00 M | $967.00 M | $953.00 M | $345.00 M | $410.00 M |
Cash and Short-Term Investment Growth | -44.36% | 1.45% | 175.97% | -15.80% | 0.00% |
Long Term Debt | $4.26 B | $3.24 B | $3.03 B | $2.88 B | $2.65 B |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $10.51 B | $9.11 B | $7.78 B | $6.18 B | $4.53 B |
Total Assets Growth | 15.31% | 17.17% | 25.75% | 36.48% | 0.00% |
Inventories | $702.00 M | $563.00 M | $324.00 M | $257.00 M | $209.00 M |
Finished Goods | $0.00 M | $151.00 M | $123.00 M | $115.00 M | $91.00 M |
Short Term Debt | $45.00 M | $91.00 M | $88.00 M | $77.00 M | $72.00 M |
Total Liabilities | $5.71 B | $4.84 B | $4.27 B | $3.90 B | $3.44 B |
2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $3.22 B | $2.82 B | $2.73 B | $2.58 B | $2.61 B |
Cash and Short-Term Investment | $538.00 M | $880.00 M | $915.00 M | $2.02 B | $967.00 M |
Cash and Short-Term Investment Growth | -38.86% | -3.83% | -54.68% | 108.79% | 0.00% |
Long Term Debt | $4.26 B | $4.16 B | $4.19 B | $4.23 B | $3.24 B |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $10.51 B | $10.32 B | $10.20 B | $10.18 B | $9.11 B |
Total Assets Growth | 1.79% | 1.17% | 0.20% | 11.75% | 0.00% |
Inventories | $702.00 M | $676.00 M | $688.00 M | $622.00 M | $563.00 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $151.00 M |
Short Term Debt | $45.00 M | $43.00 M | $43.00 M | $93.00 M | $91.00 M |
Total Liabilities | $5.71 B | $5.69 B | $5.72 B | $5.80 B | $4.84 B |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2024-10-18 | 1.76 | $1.68 M |
2025-01-17 | 2.37 | $538.80 K |
Quarter | Amount | Yield |
---|
|
|